Navigation Links
Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn's Disease
Date:5/15/2013

PRINCETON, N.J., May 15, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has initiated the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.  The program has previously received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration (FDA) for oral BDP as a treatment for pediatric Crohn's Disease.

The objective of Study BDP-PCD-01, entitled "A Phase 1 Pharmacokinetic/Pharmacodynamic Study of Oral Beclomethasone 17,21-Dipropionate (BDP) in Healthy Adolescents and Young Adults", is to determine the pharmacokinetic (PK) and pharmacodynamic (PD) profile of oral BDP in healthy young male and female adolescents and adults. This study will enroll 24 subjects, with assessments to be completed in June 2013.

The program has been designed in collaboration with an expert in PK modeling and simulation, Jeffrey S. Barrett , PhD, FCP.  Dr. Barrett is Director of both the Laboratory for Applied PK/PD and also the Pediatric Pharmacology Research Unit at The Children's Hospital of Philadelphia. He is also Professor of Pediatrics at the University of Pennsylvania Medical School.

"There are currently no FDA approved corticosteroid therapies for pediatric Crohn's disease and we believe that SGX203 has the potential to meet an important medical need in children with this serious illness," stated Kevin J. Horgan , MD, Senior Vice President & Chief Medical Officer of Soligenix. "Data from this study will be used to refine the PK model we have established with Dr. Barrett.  The PK
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
2. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
3. Soligenix to Present at World Vaccine Congress & Expo
4. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
5. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
6. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
7. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
8. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
9. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
10. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
11. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
(Date:2/26/2015)... 2015 Legislation passed today by the House ... help prevent inappropriate prescriptions in Medicare Part D from ... of Medicare Act (PIMA) of 2014 , introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... and implement the right policies, said the Pharmaceutical Care ...
(Date:2/26/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has ... - Global Strategic Business Report" report to their ... markets for Radiation Therapy Equipment in US$ Million by ... and Radiation Therapy Simulator. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") announced ... dividend of $0.18 per share of common stock, which will ... as of November 30, 2009. The December 9, 2009 extraordinary ... to a plan of complete liquidation and dissolution and an ...
... , , WAYNE, Pa., Nov. 20 ... its fiscal first quarter ended September 30, 2009. ... decreased approximately $234,000, or 2.7%, to $8,435,000 during the three-month ... period last fiscal year. The Company reported the decreased ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7
(Date:2/27/2015)... If there is one thing that drives ... head lice outbreak at their child’s school. While head lice ... is nothing short of a nightmare for many parents as ... children, or within their child’s classroom. Just when they think ... scratching again. , Local lice removal company, Lice Troopers ...
(Date:2/27/2015)... Philanthropy is a continuous force restoring people’s ... help to restore that faith by helping the people in ... husband/wife Realtor team gives to the local children in need ... while others have been added as the need arose. , ... haven and counseling for women who have suffered physical and ...
(Date:2/27/2015)... NewYork (PRWEB) February 27, 2015 The ... and trends in the global celiac disease market. It ... outlook, research and development activities, and investments. , Celiac ... of gluten damages the small intestine. Celiac disease often ... in every 100 people is affected by celiac disease ...
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 UAS ... Adult Cubes, at Natural Products Expo West, March 6 ... are very excited to release the hands down best ... cream taste with an extra zing of Vitamin C. ... Cubes, winner of the NutrAward 2014, Delicious Living’s Supplement ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The Willliams ... Plant in Lincoln County, Wyoming. The plant processes ... preparation for interstate natural gas pipeline transport. It also ... The Opal plant initially began operations in 1958, and ... growing natural gas production in Wyoming. The plant ...
Breaking Medicine News(10 mins):Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... sickening erotica fantasies, two US teenagers in the Florida state ... woman, forcing her 12-year-old son to join the outrage , ... ,Authorities allege Avion Lawson, 14, and Nathan Walker, ... who forced their way into the woman's apartment in a ...
... of The Women's and Children's Hospital, Adelaide in Australia has ... the staff there are exposed to every day. ... of problems with ageing facilities in two of the hospital's ... risk". ,It states: "WCH is experiencing immediate facilities, ...
... Nora Ali, daughter of Bangladeshi immigrants to the United States, ... 17, won the final competition, held in Alabama Saturday, by ... said Wednesday, quoting website wcco.com. ,"I just want ... company with my elder sister who does stem cell research. ...
... developing the world's first vaccine against dengue fever as Singapore ... Friday. ,Clinical tests on up to 3,000 people ... Stephenne, GlaxoSmithKline Biologicals president. ,"We've been working on ... more or less," The Straits Times quoted Stephenne as saying. ...
... researchers say that a single drug for keeping both ... diabetes under check may soon be available. ... Medicine and Pharmacology at Tulane University School of Medicine, ... Sulfonylurea-based therapy has been found to significantly reduce glucose ...
... 36 percent since last year, local press reported Sunday, as ... ,The outbreak has killed 17 people in Thailand ... year, the English-language Nation newspaper reported, quoting figures from the ... by the virus, which is especially dangerous in children and ...
Cached Medicine News:Health News:US Teens Charged With Gang Raping a Woman 2Health News:US Teens Charged With Gang Raping a Woman 3Health News:Concerns Raised Over Risks for Patients and Staff in Australian Hospital 2